Canada markets open in 8 hours 27 minutes

Provectus Biopharmaceuticals, Inc. (PVCT)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.1648-0.0052 (-3.06%)
At close: 02:03PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
1,756
1,749
2,389
2,608
2,813
-
Selling General and Administrative
1,423
1,732
2,025
2,055
2,145
-
Total Operating Expenses
2,575
2,910
3,391
4,636
4,932
-
Operating Income or Loss
-2,575
-2,910
-3,391
-4,636
-4,932
-
Interest Expense
227.75
216.214
163.691
961.698
1,748
-
Total Other Income/Expenses Net
-
24.227
0.433
58.174
-1.273
-
Income Before Tax
-2,778
-3,102
-3,555
-5,540
-6,678
-
Income from Continuing Operations
-2,778
-3,102
-3,555
-5,540
-6,678
-
Net Income
-2,778
-3,102
-3,555
-5,540
-6,678
-
Net Income available to common shareholders
-2,778
-3,102
-3,555
-5,540
-6,678
-
Basic EPS
-0.01
-
-0.01
-0.01
-0.02
-0.02
Diluted EPS
-0.01
-
-0.01
-0.01
-0.02
-0.02
Basic Average Shares
419,502
-
419,470
408,223
393,252
386,594
Diluted Average Shares
419,502
-
419,470
408,223
393,252
386,594